What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

Diagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?

What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.

What do we know? What do we need to know?

High Stakes Require More Than Just Talk: What to Do About Corruption in Health Systems; Comment on “We Need to Talk About Corruption in Health Systems”

Reluctance to talk about corruption is an important barrier to action. Yet the stakes of not addressing corruption in the health sector are higher than ever. Corruption includes wrongdoing by individuals, but it is also a problem of weak institutions captured by political interests, and underfunded, unreliable administrative systems and healthcare delivery models. We ur...

The life cycle of the oncology nurse: do we know what we need to know?

Digital Object Identifi er: 10.1188/06.ONF.1047 The better we understand ourselves and the nature of the work that we do, the better able we will be to mold the next generation. In the first years of my tenure as editor of the Oncology Nursing Forum, I had the opportunity to edit a supplement to the September 1994 issue that contained articles based on research sponsored by the Oncology Nursing...

Do We Know What We Do not Know? A Response to Celine Bonnet